14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for NVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 125.18 1.73 %
R2 124.24 0.96 %
R1 123.65 0.488 %
Current price: 123.05
Support S1 121.76 -1.05 %
S2 121.17 -1.53 %
S3 120.22 -2.30 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 135.92 10.46 %
R2 133.07 8.14 %
R1 124.02 0.788 %
Current price 123.05
Support S1 122.23 -0.666%
S2 118.26 -3.89%
S3 117.61 -4.42%

NVO Predictions History

1 year ago
JS predicted that NVO for 2022-05-12 is going $102.57 (96.61%)

3 years ago
JS predicted that NVO for 2021-02-16 is going $74.72 (-1.45%)

3 years ago
Bad Form predicted that NVO for 2021-02-16 is going $66.42 (-12.40%)

Rank:

3 years ago
Nick Parton predicted that NVO for 2021-02-16 is going $76.00 (0.24%)

Rank:

3 years ago
JS predicted that NVO for 2021-02-05 is going $71.21 (-0.27%)

3 years ago
TheThriller predicted that NVO for 2021-02-05 is going

Rank:

3 years ago
Jamil Johnson predicted that NVO for 2021-02-05 is going

Rank:

3 years ago
JS predicted that NVO for 2021-01-25 is going $72.65 (-0.72%)

3 years ago
MichaelDilloway predicted that NVO for 2021-01-25 is going

Rank:

3 years ago
Baltzera predicted that NVO for 2021-01-25 is going

Click to get the best stock tips daily for free!

About Novo Nordisk A/S

Novo Nordisk A/S Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ... NVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT